e.g. Tata motors, Reliance MF, 500570

Kilitch Drugs(I) Ltd. - Research Center

524500 KILITCH Group (B) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 181.59 131.60 117.78 105.16 70.02
Expenses
Material consumed 93.59 67.72 60.87 62.36 39.88
Manufacturing expenses 2.61 2.36 2.06 2.00 1.57
Personnel expenses 10.03 7.91 7.47 6.15 5.22
Selling expenses 1.87 0.06 0.09 0.02 0.02
Adminstrative expenses 42.65 33.22 30.13 23.63 18.12
Expenses capitalised - - - - -
Cost of sales 150.75 111.28 100.61 94.16 64.81
Operating profit 30.84 20.32 17.17 11.00 5.21
Other recurring income 13.72 6.19 4.60 4.56 4.19
Adjusted PBDIT 44.55 26.51 21.77 15.56 9.40
Financial expenses 2.13 1.91 0.99 0.66 0.75
Depreciation 1.74 1.24 1.34 0.96 1.14
Other write offs - - - - -
Adjusted PBT 40.69 23.35 19.45 13.93 7.51
Tax charges 9.53 5.78 3.73 3.40 1.35
Adjusted PAT 31.16 17.57 15.72 10.53 6.16
Non recurring items - - - - -
Other non cash adjustments - - - - -
Reported net profit 31.16 17.57 15.72 10.53 6.16
Earnigs before appropriation 162.69 131.53 113.96 98.24 87.71
Equity dividend - - - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 162.69 131.53 113.96 98.24 87.71
Close
Add Kilitch Drugs(I) Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Kilitch Drugs(I) Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback